Trident Texofab Reaches New 52-Week High Amid Strong Market Momentum

Jan 23 2025 09:35 AM IST
share
Share Via
Trident Texofab has reached a new 52-week high of Rs. 184.8, reflecting strong momentum with a 20.08% gain over four days. The stock is trading above multiple moving averages and has delivered impressive annual returns of 187.38%, significantly outperforming the Sensex's 8.47% return.
Trident Texofab has recently achieved a new 52-week high of Rs. 184.8, marking a significant milestone for the microcap company in the trading industry. Over the past four days, the stock has gained 20.08%, demonstrating strong momentum and outperforming its sector by 3.55%.

The stock's intraday high of Rs. 184.8 represents a 3.79% increase, reinforcing its upward trajectory. Trident Texofab is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a sustained positive trend in price movement.

In terms of annual performance, Trident Texofab has delivered impressive returns of 187.38%, significantly surpassing the Sensex's 8.47% return over the same period. Despite this strong performance, there are indications of a cautious outlook from some market observers.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Trident Texofab Ltd is Rated Sell
Dec 25 2025 12:58 PM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Dec 05 2025 08:41 AM IST
share
Share Via
Is Trident Texofab technically bullish or bearish?
Dec 04 2025 08:47 AM IST
share
Share Via
How has been the historical performance of Trident Texofab?
Dec 03 2025 10:55 PM IST
share
Share Via